Federal contract award
75N95021P00034
SARS-COV-2 NUCLEOCAPSID AND SPIKE ALPHALISA ASSAYS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $39.5K |
| Current contract value | $39.5K |
| Potential contract value / ceiling | $39.5K |
| Start date | Dec 9, 2020 |
| Current end date | Jan 9, 2021 |
| Potential end date | Jan 9, 2021 |
| Latest award activity | May 27, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 27, 2026 | P00002 | $-65 | FY26 UDO INITIATIVE - SARS-COV-2 NUCLEOCAPSID AND SPIKE ALPHALISA ASSAYS |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Renato Gomes | Contact | renato.gomes@nih.gov 3014512596 | Source | Dec 1, 2020 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.